Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from IDEOlogy Health, News & Media Website, .
Our purpose, passion, and mission — to help patients receive the best treatment options — drives us to provide healthcare professionals with the latest in medical best practices for better patient outcomes.
A preview from co-chairs Stephen Liu, MD and Tina Cascone, MD, PhD on what to expect at our TLC Conference starting tomorrow.
Stephen Liu, MD, and Tina Cascone, MD, PhD, share what attendees can expect at the first ever Texas Lung Cancer Conference, an upcoming two-day CME meeting endorsed by the IASLC.
A huge thanks to our Silver Sponsor, IDEOlogy Health for supporting our Austin Student Visionaries of the Year Campaign! Thank you for all you do in support of our mission to create a world without blood cancers!
The 2022 Targeted Therapies of Lung Cancer Meeting goes live on Tuesday at 2PM ET! Follow us for conference updates including the thought leaders attending! https://bit.ly/3JqX1uJ
The IASLC 2022 Targeted Therapies of Lung Cancer Meeting will take place February 23 – 26, 2022 at the Fairmont Miramar in Santa Monica, California, USA
IDEOlogy Health is looking for a creative, passionate, and energetic VP, Scientific Affairs to lead the development of scientific and medical content and the ex*****on of various IDEOlogy Health projects. Check out the listing of our available jobs, including Vice President of Scientific Affairs, on our LinkedIn page! https://bit.ly/3JDk5GP
Heart Failure Awareness Week begins February 13! Join Heart Failure Society of America - HFSA and support the research, education, and advocate to fight for heart failure patients! https://bit.ly/3rpEyZe
February 13-20, 2022 is Heart Failure Awareness Week! Join HFSA as we promote heart failure awareness, patient education, and prevention during . This year's theme is Heart Success: Function, Not Failure.
Research shared by News Medical, states, "Experiments in hamsters recorded over time revealed that downregulation of olfactory neuron receptors persisted after short-term changes that might affect the sense of smell had naturally recovered. The authors say this suggests that COVID-19 causes longer-lasting disruption in chromosomal regulation of gene expression, representing a form of "nuclear memory" that could prevent the restoration of olfactory receptor transcription even after SARS-CoV-2 is cleared." https://bit.ly/3Gx9evU
Researchers have discovered a mechanism that may explain why people with COVID-19 lose their sense of smell.
! Do you enjoy working with others in a collaborative environment to bring the most up-to-date information to physicians? Check out the listing of our available jobs on our LinkedIn page. https://bit.ly/3iDP5LB
IDEOlogy Health | 585 followers on LinkedIn. Better Decisions Begin With Better Information. | When the speed of scientific advancements challenge healthcare professionals to stay up-to-date on clinical developments, IDEOlogy Health helps separate the signal from the noise.
New research from American Heart Association shares that healthy living could alter the risk of heart disease in patients. "Ideal adherence to LS7 recommendations was associated with lower lifetime risk of CHD for all individuals, especially in those with high genetic susceptibility. In Black participants, adherence to LS7 guidelines contributed to lifetime risk of CHD more so than current PRSs. Improved PRSs are needed to properly evaluate genetic susceptibility for CHD in diverse populations." https://bit.ly/3rrrSB5
Background: Understanding the effect of lifestyle and genetic risk on the lifetime risk of coronary heart disease (CHD) is important to improving public health initiatives. Our objective was to quant
At IDEOlogy, we offer medical advances right at your fingertips through non-promotional Sound Bites. Check out our website and other networks to today! Hematology Oncology https://bit.ly/3rzDbWe
IDEOlogy Health is disrupting the status quo to inform physicians with up-to-the-minute scientific treatment advances in different diseases right at their fingertips.
Today is ! Show your support in raising awareness of the cancer care equity gap. All cancer patients deserve care regardless of age, socioeconomic status, and location of residency. Join here: https://bit.ly/3u9O1pe
Researchers from the Boston University School of Medicine discovered a protein that facilities entry of into human cells. "Severe endothelial injury, vascular thrombosis, and obstruction of alveolar capillaries are common features of severe COVID-19. Identification of vimentin as a host attachment factor for SARS-CoV-2 can provide new insight into the mechanism of SARS-CoV-2 infection of the vascular system and can lead to the development of novel treatment strategies." https://bit.ly/3HcF8iw
Researchers have identified extracellular vimentin as an attachment factor that facilitates SARS-CoV-2 entry into human cells. Vimentin is a structural protein that is widely expressed in the cells of mesenchymal origin such as endothelial cells and a potential novel target against SARS-CoV-2, which...
Do you enjoy working with others in a collaborative environment to bring the most up-to-date information to physicians? Check out the listing of our available jobs on our LinkedIn page. https://bit.ly/3iDP5LB
February is American Heart Month! can negatively your patients' health, leading to a heart attack or stroke. The CDC offers great resources for health care professionals including lifestyle changes and treatment options for . https://bit.ly/34feM0E
Share resources, graphics, and messages about hypertension.
At IDEOlogy, we understand how quickly scientific clinical data can change. We offer medical advances right at your fingertips through non-promotional Sound Bites. Check out our website and to our other channels today! IDEO Hematology IDEO Oncology https://bit.ly/3rzDbWe
IDEOlogy Health is disrupting the status quo to inform physicians with up-to-the-minute scientific treatment advances in different diseases right at their fingertips.
Jing Sun, MD, MPH, PhD, of the Johns Hopkins Bloomberg School of Public Health told Healio, "Persons with immune dysfunction still have a substantial risk of COVID-19 infection even after their full vaccination. Therefore, continued use of nonpharmaceutical interventions — eg, mask-wearing, social distancing, avoidance of travel and crowds — and alternative vaccine strategies — eg, additional doses or immunogenicity testing — should be recommended in clinical practice." https://bit.ly/32lVXs9
Although vaccines reduce the overall risk for COVID-19 regardless of immune status, patients with immune dysfunction are at a “substantial risk” for breakthrough infection versus those without, according to data. Specifically, the researchers found that patients with rheumatoid arthritis...
According to a report from American Journal of Respiratory and Critical Care Medicine, symptoms were related to asthma severity. "The researchers reported significantly higher risks for ICU admission and mortality among patients with asthma and regular ICS plus add-on therapy and those with frequent exacerbations." https://bit.ly/3FPWCQh
In a new study, all asthma phenotypes were associated with risk for more severe COVID-19 outcomes, except for type 2 inflammation, researchers reported in the American Journal of Respiratory and Critical Care Medicine. Researchers conducted a study to analyze the effect of asthma phenotype on COVID-...
We are hiring! Do you enjoy working with others in a collaborative environment to bring the most up-to-date information to physicians? Check out the listing of our available jobs on our LinkedIn page. https://bit.ly/3iDP5LB
According to a study shared by Healio, Coffee could help reduce the risk of endometrial cancer. "The inverse association between high coffee consumption and the risk for endometrial cancer was significant among the cohort and case-control studies alike, especially for caffeinated coffee, suggesting a protective link." https://bit.ly/3qMUhRS
Coffee consumption may reduce the risk for endometrial cancer, according to a study published in The Journal of Obstetrics and Gynaecology Research. Yu Gao, of the departments of obstetrics and gynecology at Liangxiang Hospital of Beijing Fangshan District and at Peking Union Medical College Hospita...
At IDEOlogy Health, we focus on innovation, patients, and are scientifically driven. Follow us and our other channels to stay up-to-date on , , and . IDEO Oncology IDEO Hematology https://bit.ly/3rzDbWe
IDEOlogy Health is disrupting the status quo to inform physicians with up-to-the-minute scientific treatment advances in different diseases right at their fingertips.
Dr. Cynthia McMurray from Berkeley Lab is working on the development of a test that could detect early Alzheimer's. "This is an integrated technique, which is a much better method for looking at states. We are not following a molecule in that cell, we are looking at this integrated signature that tells us the average of what that cell is doing. If it is in the disease category, it is a signature of disease." Hopefully, this method will become a baseline for Alzheimer's diagnosis, allowing treatment options to broaden and begin earlier. https://bit.ly/3GvtPBH
In this interview, we spoke to Dr. Cynthia McMurray about her latest research into Alzheimer's disease.
Results from a study conclude that myocardial injury due to increases the risk of hospitalization. "The presence of ongoing COVID-19-related symptoms at 6 months was more common in patients with cardiac injury compared with low-level positive troponin and undetectable troponin (56.4% vs. 30.7% vs. 12.8%, respectively), but the difference did not reach statistical significance." Healio https://bit.ly/3A3GFVs
Among patients hospitalized with COVID-19, myocardial injury as determined by high-sensitivity cardiac troponin T was linked to mortality and ongoing COVID-19 symptoms, researchers reported. Brittany Weber, MD, PhD, cardiologist at Brigham and Women’s Hospital and instructor in medicine at Har...
We are hiring! Do you enjoy working with others in a collaborative environment to bring the most up-to-date information to physicians? Check out the listing of our available jobs on our LinkedIn page. https://bit.ly/3iDP5LB
Please help us welcome Cameron Lush who is joining us today as Chief Commercial Officer. We are thrilled to have him on our leadership team. 🌟 Press release: https://hubs.ly/Q012mnv-0
At IDEOlogy Health, we focus on innovation, patients, and are scientifically driven. Follow us and our other channels to stay up-to-date on , , and . https://bit.ly/3rzDbWe
IDEOlogy Health is disrupting the status quo to inform physicians with up-to-the-minute scientific treatment advances in different diseases right at their fingertips.
The U.S. Multi-Society Task Force made updates to screening recommendations, based on recent data. “Because precancerous lesions are not reportable to regional or national health agencies, we have not had this degree of information to guide our recommendations. Our study provides an important piece of the puzzle and supports the recommendation changing the screening age to 45.” https://bit.ly/33jTHSe
Increased incidence of early-onset colorectal cancer and precancerous polyp diagnoses among patients at a younger age supported the recommendation for CRC screening at age 45 for all average risk individuals, according to a study. “We have known for many years that rates of colorectal cancer a...
A study published in The New England Journal of Medicine shares encouraging data from a recent study on sickle cell anemia treatment! "All 35 patients with sickle cell anemia who received LentiGlobin infusion in this phase 1 to 2 trial experienced engraftment. In the 24 months before enrollment, the patients experienced a median of 3.5 vaso-occlusive events per year (range, 2.0 to 13.5)." https://bit.ly/3Fb9D6r
An update on the investigational gene therapy LentiGlobin for sickle cell disease and research on complications and outcomes of this disorder.
! Do you have a passion for healthcare, medical science, and working in a collaborative atmosphere? Check out the listing of our available jobs on our LinkedIn page. https://bit.ly/3iDP5LB
Although the transmission of the Omicron variant has risen across the country, experts are stating, "vaccine breakthrough infections are far less likely to transmit from the index patient to contacts than infections in partially or unvaccinated individuals." This study supports the importance of vaccinations and informs public health policymakers on what the future of could look like. https://bit.ly/34EdL2r
A new study displays that vaccine breakthrough COVID-19 infections are far less likely to transmit from the index patient to contacts than infections in partially or unvaccinated individuals.
IDEOlogy Health is disrupting the status quo by informing physicians with up-to-the-minute scientific treatment advances in different diseases right at their fingertips. Join our network of experts to stay in the know on all things , , and . https://bit.ly/3rzDbWe
IDEOlogy Health is disrupting the status quo to inform physicians with up-to-the-minute scientific treatment advances in different diseases right at their fingertips.
An observational study in JAMA Oncology with 20 years of follow-up found that while patients with DCIS who underwent more aggressive treatment generally had a lower risk of ipsilateral recurrence, their risk of dying from breast cancer was the same as those with less treatment. https://bit.ly/3EQEfdi
Working across disciplines and ongoing research might help
Be the first to know and let us send you an email when IDEOlogy Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to IDEOlogy Health:
IDEOlogy Health sat down with Texas Oncology's CEO Dr. Steve Paulson to chat about our exciting collaboration. We look forward to what the future holds. Want to learn more? Click the link to view the whole conversation: https://bit.ly/3iisG7m #ASCO21
Stay up to date with the latest clinical data broken down by the experts in our network. Experts like Drs. Johanna Bendell, Rana McKay, Jack West, Hope Rugo, Toni Bekaii-Saab, Brad Monk, Mark Socinski and Evan Yu will keep you informed with all you need to know in oncology.
Want your business to be the top-listed Media Company?
